Discovery of new biomarkers of heart failure in the exhaled air using ion mobility spectrometry – a prospective cohort study

• Conditions: I50.9; Heart failure, unspecified

• Registration Number: DRKS00027445
• Lead Sponsor: Immanuel Klinikum Bernau Herzzentrum Brandenburg Hochschulklinikum der Medizinischen Hochschule Brandenburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-27
• Study Completion: 2022-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

heart insufficiency with symtoms at rest
NTproBNP > 2.000 pg/ml
written consent of the patient

Exclusion Criteria

- severe impairment of lung function with inability to conduct a slow expiratory VC maneuver
- lack of cooperation or legal capacity of the patient or suspicion that the necessary data of the patient can not be recorded
- Pregnancy
- Proven COVID disease

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evaluation of heart disease dependend Biomarker in exhaled breath

Secondary Outcome Measures

Name	Time	Method
Practicability for establishing screening for cardiac markers in the exhaled breathe